The powerful consulting firm McKinsey agreed to pay $573 million to settle investigations into its role in helping “turbocharge” opioid sales.
Wednesday, February 3, 2021 8:12 PM EST
The firm has reached the agreement with attorneys general in 47 states, the District of Columbia and five territories, according to five people familiar with the negotiations.
The settlement comes after lawsuits unearthed a trove of documents showing how McKinsey worked to drive sales of Purdue Pharma’s OxyContin painkiller amid an opioid epidemic in the United States that has contributed to the deaths of more than 450,000 people over the past two decades.
The New York Times
